丙酮酸激酶
瓦博格效应
细胞生物学
糖酵解
化学
生物
癌症研究
生物化学
激酶
新陈代谢
作者
Eva M. Pålsson‐McDermott,Annie M. Curtis,Gautam Goel,Mario Lauterbach,Frederick J. Sheedy,Laura E Gleeson,Mirjam W.M. van den Bosch,Susan R. Quinn,Raquel Domingo-Fernandéz,Daniel Johnston,Jian‐kang Jiang,William J. Israelsen,Joseph Keane,Craig J. Thomas,Clary B. Clish,Matthew G. Vander Heiden,Ramnik J. Xavier,Luke O'neill
出处
期刊:Cell Metabolism
[Cell Press]
日期:2015-01-01
卷期号:21 (1): 65-80
被引量:1110
标识
DOI:10.1016/j.cmet.2014.12.005
摘要
Summary
Macrophages activated by the TLR4 agonist LPS undergo dramatic changes in their metabolic activity. We here show that LPS induces expression of the key metabolic regulator Pyruvate Kinase M2 (PKM2). Activation of PKM2 using two well-characterized small molecules, DASA-58 and TEPP-46, inhibited LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes. Activation of PKM2 attenuated an LPS-induced proinflammatory M1 macrophage phenotype while promoting traits typical of an M2 macrophage. We show that LPS-induced PKM2 enters into a complex with Hif-1α, which can directly bind to the IL-1β promoter, an event that is inhibited by activation of PKM2. Both compounds inhibited LPS-induced glycolytic reprogramming and succinate production. Finally, activation of PKM2 by TEPP-46 in vivo inhibited LPS and Salmonella typhimurium-induced IL-1β production, while boosting production of IL-10. PKM2 is therefore a critical determinant of macrophage activation by LPS, promoting the inflammatory response.
科研通智能强力驱动
Strongly Powered by AbleSci AI